Status: current, Defined. Date: 31-Aug 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4605291000168118 | cannabidiol 25 mg / 1 mL + delta-9-tetrahydrocannabinol 25 mg / 1 mL oral liquid, 30 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4605301000168117 | delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | has MPUU | delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid | true | Inferred relationship | Some | 470546968 | |
delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | Is a | delta-9-tetrahydrocannabinol less than or equal to 1 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Canndeocare 1:1 (THC 25:CBD 25) oral liquid, 30 mL | Is a | True | delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | Inferred relationship | Some | |
Mercury Pharma MP 1:1 (THC 25:CBD 25) oral liquid, 30 mL | Is a | True | delta-9-tetrahydrocannabinol 25 mg/mL + cannabidiol 25 mg/mL oral liquid, 30 mL | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
Medicinal product pack reference set